Advanced and Metastatic Solid tumors
Conditions
Interventions
None listed
Sponsors
BeOne Medicines I GmbH
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Outcome results
None listed
A Phase 1a/1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Antitumor Activity of BG-75202, Alone and in Combination with Other Agents in Patients with Advanced Solid Tumors
For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms
Source: EU CTIS · Data processed: Mar 13, 2026